Digital PCR in Oncology: Changing the Paradigm for Systemic Therapy Administration
Cambridge Healthtech Institute speaks with Dr. Ben Ho Park of Johns Hopkins about how digital PCR is changing the field of oncology. Dr Park discusses the difference between BEAMING vs. droplet digital PCR, some of the biggest challenges with the technology, and future possibilities.
* - required fields
250 First Avenue Suite 300Needham, MA 02494P: 781.972.5400F: 781.972.5425E: email@example.com
biological therapeutic productsbiomarkers & diagnosticsbiopharma strategybioprocess & manufacturingchemistryclinical trials & translational medicinedrug & device safety
drug discovery & developmentdrug targetsgenomicshealthcareit & informaticstechnology & tools for life sciencetherapeutic indications
conferencesreportsbarnett educational servicesconsultingpublications & eNewslettersKnowledge Foundation professional services
executive teamtestimonialschi timelinemailing listcareers